Guidelines in ovarian cancer

Guidelines in ovarian cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2217/EBO.11.96

P50authorDomenica LorussoQ38524419
Giovanni ScambiaQ91909477
P2093author name stringAntonella Pietragalla
P2860cites workResults from four rounds of ovarian cancer screening in a randomized trialQ24650747
Cancer statistics, 2009Q29547625
Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysisQ33957687
International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinomaQ33963742
Early events in the pathogenesis of epithelial ovarian cancerQ37057044
MRI, CT, and PET/CT for ovarian cancer detection and adnexal lesion characterizationQ37679517
Trabectedin plus pegylated liposomal Doxorubicin in recurrent ovarian cancer.Q43048172
Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancerQ44461877
Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trialQ46221067
Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG.Q53227029
Intraperitoneal cisplatin and paclitaxel in ovarian cancer.Q53263238
Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial.Q53300225
P921main subjectovarian cancerQ172341
P304page(s)198-210
P577publication date2012-03-01
P1476titleGuidelines in ovarian cancer

Search more.